Literature DB >> 2022112

Solvent use as a precursor to intravenous drug abuse.

S H Dinwiddie1, T Reich, C R Cloninger.   

Abstract

Intravenous drug abuse (IVDA) is a significant public health threat, and ways of identifying individuals at high risk for IVDA are needed to plan strategies for intervention and treatment. Previous work had identified similarities in psychiatric diagnosis and patterns of drug use in IVDAs and solvent users. Using the same population, we found that 59 of 179 IVDAs (33.0%) reported a history of solvent use, which preceded the onset of IVDA in 41 of the 59. IVDAs with a history of solvent use were more likely to receive diagnoses of alcoholism and antisocial personality disorder (ASP) than IVDAs without solvent use. Even allowing for these coexisting psychiatric disorders, a reported history of solvent use increased the likelihood of also reporting IVDA by a factor of 3.2. Although the magnitude of risk is likely to differ in other populations, a history of solvent use may indicate individuals at high risk for IVDA, and youths who have used solvents should be considered at high risk for severe drug abuse, including IVDA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022112     DOI: 10.1016/0010-440x(91)90005-w

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  10 in total

1.  Is inhalant use a risk factor for heroin and injection drug use among adolescents in the United States?

Authors:  Li-Tzy Wu; Matthew O Howard
Journal:  Addict Behav       Date:  2006-05-19       Impact factor: 3.913

2.  Epidemiological evidence on the link between drug use and suicidal behaviors among adolescents.

Authors:  Holly C Wilcox
Journal:  Can Child Adolesc Psychiatr Rev       Date:  2004-05

3.  Influencing inhalant intentions by changing socio-personal expectations.

Authors:  Jason T Siegel; Eusebio M Alvaro; William D Crano; Jessica Skenderian; Andrew Lac; Neil Patel
Journal:  Prev Sci       Date:  2008-06-10

4.  Inhalant use initiation among U.S. adolescents: evidence from the National Survey of Parents and Youth using discrete-time survival analysis.

Authors:  James M Nonnemaker; Erik C Crankshaw; Daniel R Shive; Altijani H Hussin; Matthew C Farrelly
Journal:  Addict Behav       Date:  2011-04-09       Impact factor: 3.913

5.  Inhalant use and disorders among adults in the United States.

Authors:  Li-Tzy Wu; Christopher L Ringwalt
Journal:  Drug Alcohol Depend       Date:  2006-04-03       Impact factor: 4.492

6.  Preventing youths' use of inhalants and other harmful legal products in frontier Alaskan communities: a randomized trial.

Authors:  Knowlton W Johnson; Stephen R Shamblen; Kristen A Ogilvie; David Collins; Brian Saylor
Journal:  Prev Sci       Date:  2009-12

7.  Inhalant initiation and the relationship of inhalant use to the use of other substances.

Authors:  Stephen R Shamblen; Ted Miller
Journal:  J Drug Educ       Date:  2012

8.  Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.

Authors:  Li-Tzy Wu; William E Schlenger; Deborah M Galvin
Journal:  Drug Alcohol Depend       Date:  2006-02-17       Impact factor: 4.492

9.  Inhalant dependence: data from a tertiary care center in South India.

Authors:  Janardhanan C Narayanaswamy; Biju Viswanath; Malvika Ravi; Kesavan Muralidharan
Journal:  Indian J Psychol Med       Date:  2012-07

10.  Increased risk for hepatitis C associated with solvent use among Canadian Aboriginal injection drug users.

Authors:  Souradet Y Shaw; Kathleen N Deering; Ann M Jolly; John L Wylie
Journal:  Harm Reduct J       Date:  2010-07-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.